MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, ORGO has $598,730K in assets. $164,812K in debts. $93,679K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
361.74%
Quick Ratio
332.15%
Cash Ratio
93.56%
Debt to Asset Ratio
27.53%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Accumulated depreciation
    • Operating lease right-of-use ass...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Series a redeemable convertible ...
    • Accrued expenses and other curre...
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
93,679
Restricted cash
652
Accounts receivable, net of allowance for credit losses of 17,467 and 9,576
217,451
Inventories, net
29,627
Asset held for sale (note 8)
2,425
Prepaid expenses and other current assets
18,354
Total current assets
362,188
Property and equipment, gross
165,075
Accumulated depreciation
88,107
Construction in progress
26,743
Property and equipment, net
103,711
Intangible assets, net
9,145
Goodwill
28,772
Operating lease right-of-use assets, net
55,749
Deferred tax asset, net
29,962
Other assets
9,203
Total assets
598,730
Current portion of finance lease obligations
9,435
Current portion of operating lease obligations - related party
4,258
Current portion of operating lease obligations
4,949
Accounts payable
31,949
Accrued expenses and other current liabilities
49,533
Total current liabilities
100,124
Finance lease obligations, net of current portion
12,788
Operating lease obligations, net of current portion - related party
28,237
Operating lease obligations, net of current portion
22,470
Other liabilities
1,193
Total liabilities
164,812
Series a redeemable convertible preferred stock, 0.0001 par value 130,000 shares authorized, issued and outstanding liquidation preference of 142,217 and 131,387 at december 31, 2025 and 2024, respectively
133,789
Common stock, 0.0001 par value 400,000,000 shares authorized 127,680,424 and 126,458,784 shares issued 126,951,876 and 125,730,236 shares outstanding at december 31, 2025 and 2024, respectively
13
Additional paid-in capital
303,194
Accumulated deficit
-3,078
Total stockholders' equity
300,129
Total liabilities, redeemable convertible preferred stock, and stockholders' equity
598,730
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Accounts receivable, netof allowance for...$217,451K Cash and cashequivalents$93,679K Inventories, net$29,627K Prepaid expenses andother current assets$18,354K Asset held for sale(note 8)$2,425K Restricted cash$652K Property and equipment,gross$165,075K Construction in progress$26,743K Total current assets$362,188K Property and equipment,net$103,711K Operating leaseright-of-use assets, net$55,749K Deferred tax asset, net$29,962K Goodwill$28,772K Other assets$9,203K Intangible assets, net$9,145K Accumulated depreciation$88,107K Total assets$598,730K Total liabilities,redeemable convertible...$598,730K Total stockholders'equity$300,129K Total liabilities$164,812K Series a redeemableconvertible preferred...$133,789K Accumulated deficit-$3,078K Additional paid-in capital$303,194K Total currentliabilities$100,124K Operating leaseobligations, net of current...$28,237K Operating leaseobligations, net of current...$22,470K Finance leaseobligations, net of current...$12,788K Other liabilities$1,193K Common stock, 0.0001par value...$13K Accrued expenses andother current...$49,533K Accounts payable$31,949K Current portion offinance lease...$9,435K Current portion ofoperating lease...$4,949K Current portion ofoperating lease...$4,258K

Organogenesis Holdings Inc. (ORGO)

Organogenesis Holdings Inc. (ORGO)